Hims & Hers Health Statistics
Hims & Hers Health (82W) Stock Statistics & Valuation Metrics
Total Valuation
Hims & Hers Health has a market cap or net worth of EUR 4.02B. The enterprise value is EUR 7.81B.
- Market Cap
- EUR 4.02B
- Enterprise Value
- EUR 7.81B
Share Statistics
Hims & Hers Health has 224,935,790 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 224,935,790
- Owned by Insiders
- 4.81%
- Owned by Institutions
- 39.91%
Financial Efficiency
Hims & Hers Health’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 6.02%.
- Return on Equity (ROE)
- 0.24
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 6.02%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 961.36K
- Profits Per Employee
- 52.57K
- Employee Count
- 2,442
- Asset Turnover
- 1.09
- Inventory Turnover
- 5.31
Valuation Ratios
The current PE Ratio of Hims & Hers Health is -25.38. Hims & Hers Health’s PEG ratio is 0.57.
- PE Ratio
- -25.38
- PS Ratio
- 1.63
- PB Ratio
- 13.70
- Price to FCF
- 153.07
- Price to Operating Cash Flow
- 26.52
- PEG Ratio
- 0.57
Income Statement
In the last 12 months, Hims & Hers Health had revenue of 2.35B and earned 128.37M in profits. Earnings per share was 0.57.
- Revenue
- 2.35B
- Gross Profit
- 1.73B
- Operating Income
- 105.61M
- Pretax Income
- 123.92M
- Net Income
- 128.37M
- EBITDA
- 178.43M
- Earnings Per Share (EPS)
- 0.57
Cash Flow
In the last 12 months, operating cash flow was 183.51M and capital expenditures -152.93M, giving a free cash flow of 30.58M billion.
- Operating Cash Flow
- 183.51M
- Free Cash Flow
- 30.58M
- Free Cash Flow per Share
- 0.13
Dividends & Yields
Hims & Hers Health pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.65%
- Earnings Yield
- -3.91%
Stock Price Statistics
- Beta
- 1.55
- 52-Week Price Change
- -47.46%
- 50-Day Moving Average
- 25.10
- 200-Day Moving Average
- 23.28
- Relative Strength Index (RSI)
- 29.70
- Average Volume (3m)
- 2,069
Important Dates
Hims & Hers Health upcoming earnings date is Mar 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 09, 2026
- Next Earnings Date
- Mar 01, 2027
- Ex-Dividend Date
- ―
Financial Position
Hims & Hers Health as a current ratio of 1.90, with Debt / Equity ratio of 207.16%
- Current Ratio
- 1.90
- Quick Ratio
- 1.61
- Debt to Market Cap
- 0.13
- Net Debt to EBITDA
- 5.00
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Hims & Hers Health has paid -4.44M in taxes.
- Income Tax
- -4.44M
- Effective Tax Rate
- -0.04
Enterprise Valuation
Hims & Hers Health EV to EBITDA ratio is -49.38, with an EV/FCF ratio of 184.63.
- EV to Sales
- 1.97
- EV to EBITDA
- -49.38
- EV to Free Cash Flow
- 184.63
- EV to Operating Cash Flow
- 30.77
Balance Sheet
Hims & Hers Health has EUR 712.22M in cash and marketable securities with EUR 1.56B in debt, giving a net cash position of -EUR 848.53M billion.
- Cash & Marketable Securities
- EUR 712.22M
- Total Debt
- EUR 1.56B
- Net Cash
- -EUR 848.53M
- Net Cash Per Share
- -EUR 3.77
- Tangible Book Value Per Share
- -EUR 4.93
Margins
Gross margin is 60.45%, with operating margin of -5.95%, and net profit margin of -6.65%.
- Gross Margin
- 60.45%
- Operating Margin
- -5.95%
- Pretax Margin
- -7.74%
- Net Profit Margin
- -6.65%
- EBITDA Margin
- -3.98%
- EBIT Margin
- -7.74%
Analyst Forecast
The average price target for Hims & Hers Health is EUR 26.16, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- EUR 26.16
- Price Target Upside
- 44.71% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 12
- Revenue Growth Forecast
- 23.55%
- EPS Growth Forecast
- -229.07%
Scores
- Smart Score
- 5
- AI Score
- ―
